Our path to $[ ]M+
March 21, 2022
We are being measured against our revenue for this year and our ability to hit the targets we’ve set for ourselves across our recurring revenue and our transaction revenue. On our path to $[ ]M+ in revenue, around half of that will come from our broker dealer’s transaction revenue, where we will be delivering on our promise of seeing our borrowers through their entire capital markets life, all the way through to when they hit the institutional markets.
Our Capital Markets team has made tremendous progress in the past few weeks on several of our institutional transactions and several of them are from borrowers who are coming out of our platform and we have line of sight into over $[ ]M in revenue alone from these transactions below:
[ ]: Exclusive $[ ] term sheet was signed and the investor has just finished regulatory diligence and are now switching gears to documentation, and on track for an end of March/early April close. This transaction will net us ~$[ ] in fees.
[ ] (ABS Facility): We just received an extremely attractive term sheet for this transaction. The investor offered a $[ ] facility at [ ]% all-in cost of capital and the company is inclined to take it. This transaction will net us ~$[ ] in fees.
[ ] (Corporate Loan): After submitting a structure to [ ] that reflects our standardized deal structure, they have provided a binding verbal indication of an [ ] rating for a senior secured note at Mustang’s parent company. This is a huge win and opens up the market for all insurance companies that accept [ ] ratings. We now have a defined path and process for rated corporate deals for any of the mid market borrowers on our platform looking to graduate. We already have several borrowers in the pipeline that are ready to move forward as they were waiting to see what came out of this transaction with [ ]. This transaction will net us ~$[ ]K in fees.
These three transactions, along with others we have in the institutional pipeline, will also have a data agent fee added in, requiring these institutional investors to log into our portal to get access to our surveillance reporting, increasing our recurring revenues this year that are critical for VCs. It’s been a great few weeks on the institutional side and there’s more to come as our pipeline has 9 other deals in the works.
We’re doing all the right things to get revenue to where it needs to be for 2022, let’s keep it up 🙌
